Alberta Investment Management Corp (AIMCo)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,709
Closed -$731K 810
2024
Q3
$731K Sell
3,709
-2,642
-42% -$549K 0.01% 634
2024
Q2
$1.31M Sell
6,351
-6,001
-49% -$1.36M 0.01% 461
2024
Q1
$3.35M Hold
12,352
0.03% 307
2023
Q4
$2.92M Buy
12,352
+3,925
+47% +$772K 0.03% 330
2023
Q3
$1.65M Buy
+8,427
New +$1.73M 0.02% 500
2016
Q4
Sell
-3,295
Closed -$275K 729
2016
Q3
$275K Sell
3,295
-22,035
-87% -$1.85M ﹤0.01% 664
2016
Q2
$2.09M Sell
25,330
-4,935
-16% -$406K 0.02% 419
2016
Q1
$2.3M Buy
+30,265
New +$2.24M 0.03% 360

Other funds holding CRL

Alberta Investment Management Corp (AIMCo)'s CRL Position: Q4 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 3,709 shares — an estimated $731K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in CRL in Q1 2016 and held it in 8 quarters. The position peaked at $3.35M in Q1 2024. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 3,709 Charles River Laboratories shares in Q4 2024, an estimated $731K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Charles River Laboratories in Q1 2016 and held it in 8 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Charles River Laboratories position peaked at $3.35M in Q1 2024.
  • 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2024, filed 3 Feb 2025.